OPTN (OptiNose, Inc.) Earnings per share growth rate in current year
OptiNose, Inc. (OPTN) possesses a unique nasal drug delivery technology that has earned recognition from industry specialists. The annual EPS growth rate reflects profit dynamics, with the value holding at 52.10. This trend is supported by stable working capital sufficient to cover all liabilities. Supply stability is guaranteed through the complete outsourcing of production to certified plants in Europe and the US.
Comprehensive metric breakdowns and analytics for OptiNose, Inc. (OPTN)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
- net income and valuation multiples indicators:
OPTN - Company Net Income|Company Profit Forecast OptiNose, Inc.|OPTN - P/E Multiple|Projected Price to Earnings Ratio OptiNose Corp|OPTN - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation OptiNose Corp|OPTN - Operating profit EBITDA|Net earnings per share for the last four quarters OptiNose|OPTN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last 12 months optinose.com|OPTN - Earnings growth in current year|Expected earnings per share growth for next year OptiNose, Inc.
- revenue and sales proceeds data:
Fundamental valuation:OPTN - OptiNose Inc
The efficiency of implementing drug delivery systems into the nasal sinuses through partnerships with otolaryngologists directly impacts the net profit dynamics of OptiNose, Inc. (OPTN). This metric calculates the percentage deviation of the current earnings per share from the same period last year, measuring the pace of business scaling. Analyzing annual EPS fluctuations allows for an assessment of demand stability for innovative sinusitis treatments and helps avoid overpaying for the asset.
Main competitors
Haleon PLC - Earnings per share increase in current year|KVUE (Kenvue Corp) - Earnings growth in current year|Earnings per share growth rate in current year Verona Pharma Inc. VRNA|Earnings per share growth in current year Jyong Biotech Ltd (MENS)|LGND (ligand.com) - Earnings per share increase in current year|Earnings per share growth in current year Amneal AMRX|Perrigo Company PLC (PRGO) - Earnings per share growth rate in current year|ALVO - Earnings per share growth in current year|Earnings per share trend in current year LQDA|GLPG (Galapagos NV) - Net earnings per share growth this year|ANIP: Net earnings per one share growth for the current year|MNKD (MannKind) - Earnings growth in current year|Amphastar Pharmaceuticals Inc (AMPH) - Expected net earnings per share growth this year|Earnings per share growth in current year Pacira (PCRX)|ARS Corp - Earnings per share growth this year|Earnings per share growth in current year Theravance Biopharma TBPH|aquestive.com (AQST) - Earnings per share growth rate in current year|SCPH - Earnings per share growth in current year|Expected net earnings per share growth this year Tectonic Therapeutic, Inc. TECX|TNXP: Earnings growth in current year|Earnings per share growth rate in current year China SXT Pharmaceuticals, Inc. (SXTC)|Net earnings per share growth this year EPRX|BHST: Earnings per share increase in current year|Earnings growth in current year EXOZ|Expected net earnings per share growth this year oramed.com|Earnings per share growth in current year Entera Bio ENTX|HYFT: Earnings per share growth this year|ABVC BioPharma - Earnings growth in current year|cumberlandpharma.com (CPIX) - Net earnings per share growth this year|QNTM (Quantum BioPharma) - Net earnings per share growth this year|FGEN - Expected net earnings per share growth this year|Earnings per share growth in current year Telomir Pharma|Earnings per share growth rate in current year Rani Therapeutics Inc RANI|Earnings per share growth in current year Synergy CHC Corp (SNYR)|RLYB: Earnings per share trend in current year|Lexaria Bioscience Corp. - Net earnings per share growth this year|Net earnings per one share growth for the current year PULM (Pulmatrix Inc)|PTHL - Earnings per share growth in current year|APM (Aptorum Group Limited) - Earnings per share growth this year|Lyra Therapeutics, Inc. (LYRA) - Earnings per share growth in current year|Earnings per share trend in current year IBO (Impact BioMedical, Inc.)|TNFA (TNF Pharmaceuticals Inc.) - Earnings growth in current year|YCBD: Earnings per share increase in current year|Earnings growth in current year PRFX|Earnings growth in current year altamiratherapeutics.com (CYTO)|Earnings per share growth in current year Lipella Pharmaceuticals LIPO|Earnings per share increase in current year PIRS|PROC - Earnings per share growth in current year|Petros Pharmaceuticals Inc (PTPI) - Net earnings per share growth this year|QLI: Earnings growth in current year|ACELYRIN Inc. (SLRN) - Earnings growth in current year|Net earnings per share growth this year TFFP
